<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03249662</url>
  </required_header>
  <id_info>
    <org_study_id>si111/2017</org_study_id>
    <nct_id>NCT03249662</nct_id>
  </id_info>
  <brief_title>Efficacy of Pain Control in Different Bupivacaine Dose in Periarticular Injection in Bilateral Total Knee Arthroplasty</brief_title>
  <official_title>Efficacy of Pain Management in Different Concentrations of Bupivacaine in Periarticular Injection and Plasma Concentrations of Bupivacaine in Patients Undergoing Bilateral Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study efficacy of postoperative pain control of different concentrations of bupivacaine
      for periarticular infiltration, part of multimodal analgesia, in bilateral total knee
      arthroplasty.

      To study plasma concentration of bupivacaine in patient who received spinal anesthesia and
      single shot bilateral adductor canal block and periarticular infiltration with bupivacaine
      for safety level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adequate postoperative pain control reduce postoperative morbidity, multimodal analgesia
      techniques is used for achieve this goal. multimodal analgesia for bilateral total knee
      arthroplasty are peripheral nerve block, periarticular infiltration, NSAIDs, gabapentins and
      others. patients undergoing bilateral total knee arthroplasty in siriraj hospital receive
      spinal anesthesia, single shot bilateral adductor canal block and bilateral periarticular
      infiltration with bupivacaine so patient receive a large dose of bupivacaine. the
      investigators study the efficacy of postoperative pain of reduced dose of bupivacaine for
      periarticular infiltration. and study plasma level of bupivacaine.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 27, 2017</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain score</measure>
    <time_frame>0-24 hours postoperative</time_frame>
    <description>Numerical rating scale at rest and movement in the first 24 hours postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma bupivacaine level</measure>
    <time_frame>40 minutes after 1st articular infiltration, 15,30,45,60,90 minutes after 2nd periarticular infiltratio</time_frame>
    <description>plasma bupivacaine level at 40 minutes after 1st articular infiltration, 15,30,45,60,90 minutes after 2nd periarticular infiltration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative morphine consumption</measure>
    <time_frame>first 24 hours and 24-48 hours postoperatively</time_frame>
    <description>postoperative morphine consumption at first 24 hours and 24-48 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ambulation</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>patient can walk with assistances within 48 hours postoperatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Bilateral Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>bupivacaine 100 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bupivacaine 100 mg ketorolac 30 mg epinephrine 400 mcg add Normal saline solution(NSS) to 80 ml divided to two syringes for bilateral periarticular infiltration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine 200 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bupivacaine 200 mg ketorolac 30 mg epinephrine 400 mcg add NSS to 80 ml divided to two syringes for bilateral periarticular infiltration</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bupivacaine 200 mg</intervention_name>
    <description>bupivacaine 200 mg ketorolac 30 mg epinephrine 400 mcg add NSS to 80 ml divided to two syringes for bilateral periarticular infiltration</description>
    <arm_group_label>bupivacaine 200 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine 100 mg</intervention_name>
    <description>bupivacaine 100 mg ketorolac 30 mg epinephrine 400 mcg add NSS to 80 ml divided to two syringes for bilateral periarticular infiltration</description>
    <arm_group_label>bupivacaine 100 mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged more than 18 years old

          -  American society of anesthesiologists physical status classification 1-3

          -  Undergoing bilateral total knee arthroplasty with spinal anesthesia and single shot
             bilateral adductor canal block

        Exclusion Criteria:

          -  Allergy to bupivacaine

          -  Body weight less than 50 kilograms

          -  Hepatic disease

          -  Coagulopathy

          -  Creatinine clearance less than 60 ml/min

          -  Uncontrolled cerebrovascular disease

          -  Hematocrit less than 35%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>sukanya dej-arkom, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>sukanya dej-arkom, MD</last_name>
    <phone>+6624197000</phone>
    <phone_ext>7990</phone_ext>
    <email>sukanyadej108@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital</name>
      <address>
        <city>Bangkok Noi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sukanya dejarkom</last_name>
      <phone>+664197000</phone>
      <phone_ext>7990</phone_ext>
      <email>sukanyadej108@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Dimitris CN, Taylor BC, Mowbray JG, Steensen RN, Gaines ST. Perioperative morbidity and mortality of 2-team simultaneous bilateral total knee arthroplasty. Orthopedics. 2011 Dec 6;34(12):e841-6. doi: 10.3928/01477447-20111021-02.</citation>
    <PMID>22146199</PMID>
  </reference>
  <reference>
    <citation>Mullaji A, Kanna R, Shetty GM, Chavda V, Singh DP. Efficacy of periarticular injection of bupivacaine, fentanyl, and methylprednisolone in total knee arthroplasty:a prospective, randomized trial. J Arthroplasty. 2010 Sep;25(6):851-7. doi: 10.1016/j.arth.2009.09.007. Epub 2009 Dec 21.</citation>
    <PMID>20022457</PMID>
  </reference>
  <reference>
    <citation>Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004 Nov-Dec;29(6):564-75; discussion 524. Review.</citation>
    <PMID>15635516</PMID>
  </reference>
  <reference>
    <citation>Lapmahapaisan S, Chinachoti T, Maisat W, Kleebchan N, Chatsiricharoenkul S, Charoencholvanich K, Rungwattanakij P, Sakulpacharoen N, Sri-In J. Plasma concentrations of bupivacaine after spinal anesthesia with single shot femoral nerve block and periarticular injection in total knee arthroplasty. J Med Assoc Thai. 2014 Jul;97(7):724-9.</citation>
    <PMID>25265771</PMID>
  </reference>
  <reference>
    <citation>Andersen LÃ˜, Husted H, Otte KS, Kristensen BB, Kehlet H. High-volume infiltration analgesia in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. Acta Anaesthesiol Scand. 2008 Nov;52(10):1331-5. doi: 10.1111/j.1399-6576.2008.01777.x.</citation>
    <PMID>19025523</PMID>
  </reference>
  <reference>
    <citation>Koh IJ, Kang YG, Chang CB, Kwon SK, Seo ES, Seong SC, Kim TK. Additional pain relieving effect of intraoperative periarticular injections after simultaneous bilateral TKA: a randomized, controlled study. Knee Surg Sports Traumatol Arthrosc. 2010 Jul;18(7):916-22. doi: 10.1007/s00167-010-1051-2. Epub 2010 Jan 30.</citation>
    <PMID>20119672</PMID>
  </reference>
  <reference>
    <citation>Wulf H, Gleim M, Schele HA. Plasma concentrations of bupivacaine after lumbar sympathetic block. Anesth Analg. 1994 Nov;79(5):918-20. Erratum in: Anesth Analg 1995 Jul;81(1):213.</citation>
    <PMID>7978410</PMID>
  </reference>
  <reference>
    <citation>Lapmahapaisan S, Chinachoti T, Kongpatanakul S, Chatsiricharoenkul S, Tovnich B, Duangkaew W, Pongnarin P, Sakulpacharoen N, Somcharoen W. Plasma concentrations of bupivacaine after spinal anesthesia with single shot femoral nerve block in total knee arthroplasty. J Med Assoc Thai. 2013 Mar;96(3):312-7.</citation>
    <PMID>23539934</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2017</study_first_submitted>
  <study_first_submitted_qc>August 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2017</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>periarticular infiltration</keyword>
  <keyword>postoperative pain management</keyword>
  <keyword>plasma level of bupivacaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

